These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Pharmacogenetics--implications for health management and health care economics]. Weihrauch TR Med Klin (Munich); 2002 Jul; 97(7):420-8. PubMed ID: 12168482 [TBL] [Abstract][Full Text] [Related]
27. Drug discovery and development in the age of molecular medicine. Vallance P; Levick M Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574 [TBL] [Abstract][Full Text] [Related]
28. The DNA Rx. Advances in genetics give physicians ability to tailor drugs to patients' unique makeup. Becker C Mod Healthc; 2000 Aug; 30(36):24-8, 30, 33. PubMed ID: 11186365 [TBL] [Abstract][Full Text] [Related]
29. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
31. Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice. Vizirianakis IS Curr Drug Deliv; 2004 Jan; 1(1):73-80. PubMed ID: 16305372 [TBL] [Abstract][Full Text] [Related]
32. How to anticipate the assessment of the public health benefit of new medicines? Massol J; Puech A; Boissel JP; Therapie; 2007; 62(5):427-35. PubMed ID: 18206104 [TBL] [Abstract][Full Text] [Related]
33. Keynote review: Is declining innovation in the pharmaceutical industry a myth? Schmid EF; Smith DA Drug Discov Today; 2005 Aug; 10(15):1031-9. PubMed ID: 16055019 [TBL] [Abstract][Full Text] [Related]
34. Can pharmacogenetics help rescue drugs withdrawn from the market? Shah RR Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics: questions and concerns. Mahlknecht U; Voelter-Mahlknecht S Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671 [TBL] [Abstract][Full Text] [Related]
36. Toward personalized medicine in the neuropsychiatric field. Wong EH; Fox JC; Ng MY; Lee CM Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858 [TBL] [Abstract][Full Text] [Related]
37. Genome-wide screening for drug discovery and companion diagnostics. Roses AD Expert Opin Drug Discov; 2007 Apr; 2(4):489-501. PubMed ID: 23484757 [TBL] [Abstract][Full Text] [Related]
38. Current pharmacogenomic approaches to clinical drug development. Murphy MP Pharmacogenomics; 2000 May; 1(2):115-23. PubMed ID: 11256585 [TBL] [Abstract][Full Text] [Related]
39. Genaissance pharmaceuticals, inc. Oestreicher P Pharmacogenomics; 2002 Mar; 3(2):273-6. PubMed ID: 11972448 [TBL] [Abstract][Full Text] [Related]